Filing Details
- Accession Number:
- 0000820081-15-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-11 16:11:16
- Reporting Period:
- 2015-02-10
- Filing Date:
- 2015-02-11
- Accepted Time:
- 2015-02-11 16:11:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820081 | Cambrex Corp | CBM | Pharmaceutical Preparations (2834) | 222476135 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1192621 | M Steven Klosk | One Meadowlands Plaza East Rutherford NJ 07073 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-02-10 | 45,000 | $30.32 | 100,870 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 in Table 1 is a weighted average price. These shares were sold in multiple transactions ranging from $29.90 to $30.85 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
